Search

Linda Liang

from Mountain View, CA
Age ~50
Get Report
Also known as:
Lin Daliang
Phone and address:
128 Ada Ave APT 8, Mountain View, CA 94043
Related to:
Kathy S Hall, 66Beverly J Hiles, 86Roy Long, 67Kathy Obannon, 63Carissa Galgano, 36Virginia Lintott
Connected to:
Angela Liang, 56Angela Y Liang, 51Belle P Liang, 31Ben C Liang, 60Calvin K Liang, 46Carolyn J Liang, 45Cheryl S Liang, 61Chiao L Liang, 65Chipeng Liang, 37Chiu S Liang, 77

Linda Liang Phones & Addresses

  • 128 Ada Ave APT 8, Mountain View, CA 94043
  • Somerville, MA
  • 6 Lord Fox Run, Lincoln, RI 02865 (401) 333-6953
  • Portland, ME
  • 2116 Stuart St, Berkeley, CA 94705 (510) 848-7963
  • 2201 Glen Ave, Berkeley, CA 94709 (510) 848-7963
  • 2213 Glen Ave, Berkeley, CA 94709 (510) 848-7963
  • Santa Clara, CA
  • Manhattan, KS

Work

Company: Gap Feb 2010 Position: Assistant manager

Education

School / High School: San Francisco State University- San Francisco, CA Aug 2003 Specialities: Apparel Design and Merchandising

Skills

Payroll management • scheduling manager • photoshop • Excel

Professional Records

License Records

Linda S Liang

License #:
001157-24 - Expired
Category:
Nursing Assistant
Issued Date:
Dec 23, 1991
Expiration Date:
Oct 22, 2011
Type:
Licensed Nursing Assistant

Linda S Liang

License #:
06NAR7067 - Expired
Category:
Nursing Assistant
Issued Date:
Mar 5, 2006
Expiration Date:
Oct 22, 2011
Type:
Not Licensed - REGISTRY ONLY

Resumes

Resumes

Linda Liang Photo 1

Linda Liang

View page
Linda Liang Photo 2

Linda Liang

View page
Location:
United States
Linda Liang Photo 3

Linda Liang

View page
Location:
Greater Boston Area
Industry:
Higher Education
Linda Liang Photo 4

Linda Liang

View page
Location:
United States
Linda Liang Photo 5

Linda Liang Oakland, CA

View page
Work:
Gap

Feb 2010 to Present
Assistant Manager
Gap Inc

Jun 2001 to Present
Sales Associate, Key Holder, Supervisor, Assistant Manager
Student Fashion Association
San Francisco, CA
Sep 2008 to Feb 2009
Fashion Show Producer
Gap Inc

Jun 2007 to Oct 2007
Supervisor
Keyed Sales Associate (Expert)
Aug 2002 to Jun 2007
Gap Inc
Oakland, CA
Jun 2001 to Aug 2005
Education:
San Francisco State University
San Francisco, CA
Aug 2003 to May 2009
Apparel Design and Merchandising
Skills:
Payroll management, scheduling manager, photoshop, Excel

Business Records

Name / Title
Company / Classification
Phones & Addresses
Linda Liang
President
MAYFU BEAUTY CENTER, INC
42 Wentworth St, San Francisco, CA 94108
42 Wentworth Pl, San Francisco, CA 94108
Linda Liang
President
PRETTY ISLAND, INC
950 Stockton St No 201, San Francisco, CA 94108
950 Stockton St, San Francisco, CA 94108

Publications

Us Patents

Methods And Compositions For Treating B Cell Cancer

View page
US Patent:
20060286116, Dec 21, 2006
Filed:
May 11, 2006
Appl. No.:
11/432235
Inventors:
James McArthur - Concord MA, US
Linda Liang - Somerville MA, US
International Classification:
A61K 39/00
G01N 33/574
US Classification:
424185100, 435007230
Abstract:
Disclosed are methods for killing or retarding the growth of a B cell cancer cell, by contacting the cell with a FRIL family member molecule. Also disclosed are methods for determining if a B cell cancer is sensitive to a FRIL family member molecule, or if a B cell cancer patient will benefit from treatment with a FRIL family member molecule, by contacting a B cell cancer cell with the FRIL family member molecule and determining if growth of the cell is retarded. In addition, methods for treating a B cell cancer patient are disclosed, as well as compositions comprising a FRIL family member molecule and a chemotherapeutic, radiotherapeutic, or agent that selectively kills B cells. Also disclosed are methods for locating a B cell cancer in a patient by administering a detectably labeled FRIL family member molecule to the patient and detecting the label.

Antibody Drug Conjugate For Anti-Inflammatory Applications

View page
US Patent:
20230099074, Mar 30, 2023
Filed:
Oct 26, 2022
Appl. No.:
18/049711
Inventors:
- Rahway NJ, US
- La Jolla CA, US
Jeffrey Kern - Gilbertsville PA, US
Linda Liang - Mountain View CA, US
Sanjiv Shah - Wakefield MA, US
Dennis Zaller - Boston MA, US
Andrew Beck - San Diego CA, US
Dennis Gately - San Diego CA, US
Nick Knudsen - Escondido CA, US
Anthony Manibusan - San Diego CA, US
Jianing Wang - San Diego CA, US
Ying Sun - San Diego CA, US
Assignee:
Merck Sharp & Dohme LLC - Rahway NJ
Ambrx, Inc. - La Jolla CA
International Classification:
A61K 47/68
C07K 16/28
Abstract:
Antibody drug conjugates (ADCs) comprising an antibody conjugated to an anti-inflammatory therapeutic agent via a phosphate-based linker with tunable extracellular and intracellular stability are described.

Anti-Mertk Antibodies For Treating Cancer

View page
US Patent:
20210395392, Dec 23, 2021
Filed:
Oct 8, 2019
Appl. No.:
17/284119
Inventors:
- Princeton NJ, US
Michael Quigley - San Carlos CA, US
Virginie Lafont - Lawrence Twp NJ, US
Ginger C. Rakestraw - Somerville MA, US
Linda Liang - Mountain View CA, US
International Classification:
C07K 16/40
A61K 47/68
A61P 35/00
C07K 16/28
Abstract:
This disclosure provides isolated antibodies that bind specifically to MerTK expressed on the surface of a cell and inhibit efferocytosis by the MerTK-expressing cell. The disclosure provides methods for treating a subject afflicted with a cancer comprising administering to the subject a therapeutically effective amount of an anti-MerTK antibody as monotherapy or in combination with a checkpoint inhibitor, such as an anti-PD-1 or anti-PD-L1 antibody.

Anti-Trem1 Antibodies And Related Methods

View page
US Patent:
20210101983, Apr 8, 2021
Filed:
Oct 8, 2020
Appl. No.:
17/066401
Inventors:
- South San Francisco CA, US
Aritra Pal - San Carlos CA, US
Venkataraman Sriram - Berkeley CA, US
Leonard G. Presta - San Francisco CA, US
Tiep Tu Le - Kensington CA, US
Linda Liang - Mountain View CA, US
International Classification:
C07K 16/28
A61P 35/00
Abstract:
Provided herein are anti-TREM1 antibodies and related methods of making and using anti-TREM1 antibodies. Also provided are methods and compositions for enhancing an immune response and/or for the treatment of an immune-related condition in an individual, e.g., cancer, comprising killing, disabling, or depleting non-stimulatory myeloid cells using an anti-TREM1 antibody or antigen binding fragment thereof.

Anti-Tigit Antibodies

View page
US Patent:
20210017276, Jan 21, 2021
Filed:
Jul 27, 2020
Appl. No.:
16/939883
Inventors:
- Rahway NJ, US
Wolfgang Seghezzi - Mountain View CA, US
Linda Liang - Mountain View CA, US
Veronica Juan - Redwood City CA, US
Assignee:
Merck Sharp & Dohme Corp. - Rahway NJ
International Classification:
C07K 16/28
A61P 31/00
A61K 39/395
Abstract:
The present invention relates to anti-TIGIT antibodies, as well as use of these antibodies in the treatment of diseases such as cancer and infectious disease.

Anti-Tigit Antibodies

View page
US Patent:
20200270346, Aug 27, 2020
Filed:
May 15, 2020
Appl. No.:
16/806658
Inventors:
- Rahway NJ, US
Drake LaFace - Half Moon Bay CA, US
Gopalan Raghunathan - San Diego CA, US
Linda Liang - Mountain View CA, US
Wolfgang Seghezzi - Mountain View CA, US
Assignee:
Merck Sharp & Dohme Corp. - Rahway NJ
International Classification:
C07K 16/28
A61K 39/395
A61K 45/06
Abstract:
The present invention relates to anti-TIGIT antibodies, as well as use of these antibodies in the treatment of diseases such as cancer and infectious disease.

Anti-Trem1 Antibodies And Related Methods

View page
US Patent:
20200255529, Aug 13, 2020
Filed:
Apr 17, 2020
Appl. No.:
16/852294
Inventors:
- South San Francisco CA, US
Aritra PAL - San Carlos CA, US
Venkataraman SRIRAM - Berkeley CA, US
Leonard G. PRESTA - San Francisco CA, US
Tiep Tu LE - Kensington CA, US
Linda LIANG - Mountain View CA, US
International Classification:
C07K 16/28
A61P 35/00
Abstract:
Provided herein are anti-TREM1 antibodies and related methods of making and using anti-TREM1 antibodies. Also provided are methods and compositions for enhancing an immune response and/or for the treatment of an immune-related condition in an individual, e.g., cancer, comprising killing, disabling, or depleting non-stimulatory myeloid cells using an anti-TREM1 antibody or antigen binding fragment thereof.

Antibody Drug Conjugate For Anti-Inflammatory Applications

View page
US Patent:
20200164085, May 28, 2020
Filed:
Sep 30, 2016
Appl. No.:
15/765515
Inventors:
- Rahway NJ, US
- La Jolla CA, US
Jeffrey Kern - Gilbertsville PA, US
Linda Liang - Mountain View CA, US
Sanjiv Shah - Wakefield MA, US
Dennis Zaller - Boston MA, US
Andrew Beck - San Diego CA, US
Dennis Gately - San Diego CA, US
Nick Knudsen - Escondido CA, US
Anthony Manibusan - San Diego CA, US
Jianing Wang - San Diego CA, US
Ying Sun - San Diego CA, US
International Classification:
A61K 47/68
C07K 16/28
Abstract:
Antibody drug conjugates (ADCs) comprising an antibody conjugated to an anti-inflammatory therapeutic agent via a phosphate-based linker with tunable extracellular and intracellular stability are described.
Control profile
Linda Liang from Mountain View, CA, age ~50 Get Report